The OpenLab Foundation, which is supported by GSK to accelerate the discovery of treatments for diseases of the developing world, has a new Web site. Visit it here http://openlabfoundation.org!
-
The GeMoA consortium, composed by four academic research groups and one company from three European countries are joining efforts with the broad aim of integrating computational and experimental approaches into an innovative platform for genome-wide characterization of the mechanism-of-action for selected chemical compounds with activity against Mycobacterium tuberculosis.
This site is powered by WordPress. Theme
inspired by codium-extend.